The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic

Hongkun Hu1, Jinxin Tang1, Hua Wang1

  • 1Department of Orthopaedics, Hunan Key Laboratory of Tumor Models and Individualized Medicine, Hunan Engineering Research Center of Artificial Intelligence-Based Medical Equipment, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.

PubMed

Insights

Alternative splicing (AS) and circular RNAs (circRNAs) are dysregulated in cancer. This review explores their complex interplay, revealing how they mutually regulate each other and contribute to cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Gene Expression Regulation

Background:

  • Alternative splicing (AS) generates diverse RNA variants from a single gene.
  • Circular RNAs (circRNAs) are formed through a specific type of AS called back-splicing.
  • Both AS and circRNA biogenesis are altered in cancer, impacting cellular function.

Purpose of the Study:

  • To review the intricate relationship between alternative splicing and circular RNAs in cancer.
  • To summarize how splicing factors and RNA-binding proteins regulate circRNA biogenesis.
  • To elucidate how circRNAs influence alternative splicing events and contribute to oncogenesis.

Main Methods:

  • Literature review of studies investigating the crosstalk between AS and circRNAs in cancer.
  • Analysis of regulatory mechanisms involving splicing factors, RNA-binding proteins, and epigenetic modifications.
  • Synthesis of current knowledge on the feedback loops between circRNAs and AS in cancer progression.

Main Results:

  • AS modulates circRNA biogenesis, and circRNAs, in turn, regulate AS events.
  • Epigenetic and posttranscriptional modifications concurrently influence both AS and circRNAs.
  • The feedback loop between circRNAs and AS significantly contributes to oncogenesis and cancer progression.

Conclusions:

  • Understanding the crosstalk between AS and circRNAs provides crucial insights into cancer biology.
  • Targeting the AS-circRNA axis offers potential novel strategies for cancer therapy.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
6.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K